Search results
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition By Investing.com
Investing.com· 5 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
Morningstar· 4 days agoCuris, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company ...
MD Anderson and Replay announce FDA clearance of IND application for first-in-class PRAME-targeted...
Newswise· 4 days agoMD Anderson and Replay today announced that the Food & Drug Administration (FDA) has issued a ‘safe to proceed’ for the Investigational New Drug (IND) appli
Moleculin Announces Formation of Scientific Advisory Board to Support Development of Annamycin
KTLA-TV Los Angeles· 3 days agoMoleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...